Besides animal experiments, there is proof in the literature that direct administration of ET-1 in humans can determine sepsis-like cardiovascular changes (for example, decreased cardiac output, pulmonary artery vasoconstriction, or impairment of renal and splanchnic circulation), as well as dysfunction of the liver and lungs. This evidence concerns the gene EDN1 and Sepsis.